In vitro characterization and mouthfeel study of functionalized calcium carbonate in orally disintegrating tablets

International Journal of Pharmaceutics

Volumn 534, Issue 1-2, 2017, Pages 50-59

  Wagner Hattler, Leonie ^a   Wyss, Katharina ^a   Schoelkopf, Joachim ^b   Huwyler, Jörg ^a   Puchkov, Maxim ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b OMYA INTERNATIONAL AG   (Switzerland)

Author keywords

Functionalized calcium carbonate; In vitro disintegration kinetics; Mouthfeel study; Orally disintegrating tablet

Indexed keywords

CALCIUM CARBONATE; EXCIPIENT;

ARTICLE; DATA ANALYSIS; DRUG FORMULATION; HUMAN; IN VITRO STUDY; MATHEMATICAL MODEL; MOUTH; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SEMI STRUCTURED INTERVIEW; SENSATION; TABLET DISINTEGRATION; TIME; VISUAL ANALOG SCALE; ADULT; CHEMISTRY; DRUG DELIVERY SYSTEM; ORAL DRUG ADMINISTRATION; PROCEDURES; SOLUBILITY; TABLET; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; CALCIUM CARBONATE; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; POROSITY; SOLUBILITY; TABLETS; YOUNG ADULT;

EID: 85030873510     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.10.009     Document Type: Article

References (38)

1. Abdelbary, G., Eouani, C., Prinderre, P., Joachim, J., Reynier, J., Piccerelle, P., Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int. J. Pharm. 292 (2005), 29–41, 10.1016/j.ijpharm.2004.08.019.
2. Anabel, N.-M., Andy, W., Gloria Rocio, B.M., Pia, L.-J., Natural products for the management of xerostomia: a randomized, double-blinded, placebo-controlled clinical trial. J. Oral Pathol. Med. n/a-n/a. 46:2 (2016), 154–160, 10.1111/jop.12487.
3. Badgujar, B.P., Mundada, A.S., The technologies used for developing orally disintegrating tablets: a review. Acta Pharm. 61 (2011), 117–139, 10.2478/v10007-011-0020-8.
4. Batchelor, H., Venables, R., Ranmal, S., Tuleu, C., 2015. Oral formulations for paediatrics: Palatability studies [WWW Document]. Hosp. Pharm. Eur. URL http://www.hospitalpharmacyeurope.com/drug-delivery/oral-formulations-paediatrics-palatability-studies (accessed 6.9.17).
5. Bi, Y., Sunada, H., Yonezawa, Y., Danjo, K., Otsuka, A., Iida, K., Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull. (Tokyo) 44 (1996), 2121–2127, 10.1248/cpb.44.2121.
6. Carpenter, G.H., The secretion, components, and properties of saliva. Annu. Rev. Food Sci. Technol. 4 (2013), 267–276, 10.1146/annurev-food-030212-182700.
7. Davies, E.H., Tuleu, C., Medicines for children: a matter of taste. J. Pediatr. 153 (2008), 599–604, 10.1016/j.jpeds.2008.06.030 (e2.).
8. Dor, P.J.M., Fix, J.A., In vitro determination of disintegration time of quick-dissolve tablets using a new method. Pharm. Dev. Technol. 5 (2000), 575–577, 10.1081/PDT-100102041.
9. Douroumis, D., Practical approaches of taste masking technologies in oral solid forms. Expert Opin. Drug Deliv. 4 (2007), 417–426, 10.1517/17425247.4.4.417.
10. Gohel, M., Patel, M., Amin, A., Agrawal, R., Dave, R., Bariya, N., Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS PharmSciTech 5 (2004), 10–15, 10.1208/pt050336.
11. Guinard, J.-X., Mazzucchelli, R., The sensory perception of texture and mouthfeel. Trends Food Sci. Technol. 7 (1996), 213–219, 10.1016/0924-2244(96)10025-X.
12. Heckel, R., Density-pressure relationships in powder compaction. Trans. Metall. Soc. AIME 221 (1961), 671–675.
13. Hooper, P., Lasher, J., Alexander, K.S., Baki, G., A new modified wetting test and an alternative disintegration test for orally disintegrating tablets. J. Pharm. Biomed. Anal. 120 (2016), 391–396, 10.1016/j.jpba.2015.12.046.
14. Ilkka, J., Paronen, P., Prediction of the compression behaviour of powder mixtures by the Heckel equation. Int. J. Pharm. 94 (1993), 181–187, 10.1016/0378-5173(93)90022-8.
15. Jacob, S., Shirwaikar, A., Nair, A., Preparation and evaluation of fast-disintegrating effervescent tablets of glibenclamide. Drug Dev. Ind. Pharm. 35 (2009), 321–328, 10.1080/03639040802337021.
16. Kimura, S., Uchida, S., Kanada, K., Namiki, N., Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets. Int. J. Pharm. 484 (2015), 156–162, 10.1016/j.ijpharm.2015.02.023.
17. Kuentz, M., Leuenberger, H., Pressure susceptibility of polymer tablets as a critical property: a modified heckel equation. J. Pharm. Sci. 88 (1999), 174–179, 10.1021/js980369a.
18. Leuenberger, H., Rohera, B.D., Fundamentals of powder compression. I. The compactibility and compressibility of pharmaceutical powders. Pharm. Res. 3 (1986), 12–22, 10.1023/A:1016364613722.
19. Mennella, J.A., Reed, D.R., Mathew, P.S., Roberts, K.M., Mansfield, C.J., A spoonful of sugar helps the medicine go down: bitter masking by sucrose among children and adults. Chem. Senses 40 (2015), 17–25, 10.1093/chemse/bju053.
20. Metcalf, S., Purdy, K., Limited, A.U., 1998. Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin.
21. Morita, Y., Tsushima, Y., Yasui, M., Termoz, R., Ajioka, J., Takayama, K., Evaluation of the disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem. Pharm. Bull. (Tokyo) 50 (2002), 1181–1186, 10.1248/cpb.50.1181.
22. Narazaki, R., Harada, T., Takami, N., Kato, Y., Ohwaki, T., A new method for disintegration studies of rapid disintegrating tablet. Chem. Pharm. Bull. (Tokyo) 52 (2004), 704–707, 10.1248/cpb.52.704.
23. O'Sullivan, E.A., Curzon, M.E.J., Salivary factors affecting dental erosion in children. Caries Res. 34 (2000), 82–87, 10.1159/000016574.
24. Orubu, E.S., Tuleu, C., Medicines for children: flexible solid oral formulations. Bull. World Health Organ. 95 (2017), 238–240, 10.2471/BLT.16.171967.
25. Porter, S.R., Scully, C., Hegarty, A.M., An update of the etiology and management of xerostomia. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol. 97 (2004), 28–46, 10.1016/j.tripleo.2003.07.010.
26. Poukas, V.S., Pollard, J.R., Anderson, C.T., Rescue therapies for seizures. Curr. Neurol. Neurosci. Rep. 11 (2011), 418–422, 10.1007/s11910-011-0207-x.
27. Rameesa, C.K., Drisya, M.K., Orodispersible tablet: a patient friendly dosage form (a review). Bali Med. J. 4 (2015), 17–20.
28. Rauck, R.L., Tark, M., Reyes, E., Hayes, T.G., Bartkowiak, A.J., Hassman, D., Nalamachu, S., Derrick, R., Howell, J., Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain. Curr. Med. Res. Opin. 25 (2009), 2877–2885, 10.1185/03007990903368310.
29. Handbook of pharmaceutical excipients. Rowe, R.C., Sheskey, P.J., Quinn, M.E., (eds.) Pharmaceutical Press and American Pharmacists Association, 6th edition, 2009.
30. Schiermeier, S., Schmidt, P.C., Fast dispersible ibuprofen tablets. Eur. J. Pharm. Sci. 15 (2002), 295–305, 10.1016/S0928-0987(02)00011-8.
31. Scott, J., Huskisson, E.C., Graphic representation of pain. Pain 2 (1976), 175–184, 10.1016/0304-3959(76)90113-5.
32. Sohi, H., Sultana, Y., Khar, R.K., Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev. Ind. Pharm. 30 (2004), 429–448, 10.1081/DDC-120037477.
33. Stirnimann, T., Maiuta, N.D., Gerard, D.E., Alles, R., Huwyler, J., Puchkov, M., Functionalized calcium carbonate as a novel pharmaceutical excipient for the preparation of orally dispersible tablets. Pharm. Res. 30 (2013), 1915–1925, 10.1007/s11095-013-1034-3.
34. Stirnimann, T., Atria, S., Schoelkopf, J., Gane, P.A.C., Alles, R., Huwyler, J., Puchkov, M., Compaction of functionalized calcium carbonate, a porous and crystalline microparticulate material with a lamellar surface. Int. J. Pharm. 466 (2014), 266–275, 10.1016/j.ijpharm.2014.03.027.
35. Strickley, R.G., Iwata, Q., Wu, S., Dahl, T.C., Pediatric drugs–a review of commercially available oral formulations. J. Pharm. Sci. 97 (2008), 1731–1774, 10.1002/jps.21101.
36. Washburn, E.W., The dynamics of capillary flow. Phys. Rev. 17 (1921), 273–283, 10.1103/PhysRev.17.273.
37. Zhao, N., Augsburger, L.L., The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS PharmSciTech 6 (2005), E120–E126, 10.1208/pt060119.
38. Zhao, N., Augsburger, L.L., The influence of product brand-to-brand variability on superdisintegrant performance a case study with croscarmellose sodium. Pharm. Dev. Technol. 11 (2006), 179–185, 10.1080/10837450600561281.